Clinical Trial Update: Pembrolizumab Plus Olaparib in LA-HNSCC [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating pembrolizumab in combination with olaparib for locally advanced head and neck squamous cell carcinoma is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Lynparza (olaparib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: ACTIVE_NOT_RECRUITING